Your browser doesn't support javascript.
loading
Immunogenicity study of engineered ferritins with C- and N-terminus insertion of Epstein-Barr nuclear antigen 1 epitope.
Qu, Yiran; Zhang, Bingyang; Wang, Yingli; Yin, Shuang; Pederick, Jordan L; Bruning, John B; Sun, Yan; Middelberg, Anton; Bi, Jingxiu.
Afiliação
  • Qu Y; School of Chemical Engineering and Advanced Materials, Faculty of Engineering, Computer and Mathematical Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Zhang B; School of Chemical Engineering and Advanced Materials, Faculty of Engineering, Computer and Mathematical Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Wang Y; Shanxi University of Chinese Medicine, Shanxi, China.
  • Yin S; School of Chemical Engineering and Advanced Materials, Faculty of Engineering, Computer and Mathematical Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Pederick JL; Institute for Photonics and Advanced Sensing, School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia; Department of Molecular and Cellular Biology, School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Bruning JB; Institute for Photonics and Advanced Sensing, School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia; Department of Molecular and Cellular Biology, School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
  • Sun Y; Department of Biochemical Engineering and Key Laboratory of Systems Bioengineering of the Ministry of Education, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
  • Middelberg A; Division of Research and Innovation, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Bi J; School of Chemical Engineering and Advanced Materials, Faculty of Engineering, Computer and Mathematical Sciences, The University of Adelaide, Adelaide, South Australia 5005, Australia. Electronic address: jingxiu.bi@adelaide.edu.au.
Vaccine ; 39(34): 4830-4841, 2021 08 09.
Article em En | MEDLINE | ID: mdl-34284876
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Infecções por Vírus Epstein-Barr Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Infecções por Vírus Epstein-Barr Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália